Chidozie Ugwumba reports 1.92M Clene shares (NASDAQ: CLNN) 14.8%

Rhea-AI Filing Summary

Clene Inc. disclosure: 1,915,650 shares beneficially owned representing 14.8% of Common Stock. The filing states this total includes 741,292 shares plus warrants exercisable into 375,000 Tranche A, 375,000 Tranche B, and 424,358 Common Stock Purchase Warrant shares, based on 11,778,307 shares issued and outstanding per the Prospectus Supplement 01/09/2026.

Insights

Equity Ownership Analyst

Holder reports a sizeable 1.92M-share stake equal to 14.8%.

The filing amends beneficial ownership to reflect 1,915,650 total shares, explicitly counting 1,915,650 as sole voting and dispositive power. The breakdown lists 741,292 issued shares plus exercisable warrants totaling 1,174,358 shares; the underlying outstanding base is 11,778,307 shares as of 01/09/2026.

Cash‑flow treatment and any planned dispositions are not stated in the excerpt; subsequent filings would disclose transactions if they occur. Holdings reported here are a snapshot of ownership and exercisable instruments as declared by the reporting person.

Capital Markets Counsel

This amendment clarifies beneficial ownership and exercisable warrants tied to the holder's position.

The statement ties the 14.8% figure to the issuer's Prospectus Supplement, anchoring percentage to an 01/09/2026 outstanding share count. It lists exercisable warrants by tranche and a separate purchase warrant, which are treated as beneficially owned for reporting purposes.

Regulatory implications are routine: the filing updates public ownership records. Any changes in voting or dispositions would appear in future amendments or market transaction reports.

Key Figures

Beneficially owned: 1,915,650 shares Ownership percentage: 14.8% Issued shares (component): 741,292 shares +4 more

7 metrics

Beneficially owned 1,915,650 shares Amendment No.2 Schedule 13G/A; Reporting Person sole voting/dispositive power

Ownership percentage 14.8% Calculated using 11,778,307 shares outstanding from Prospectus Supplement <date>01/09/2026</date>

Issued shares (component) 741,292 shares Issued common stock held by Reporting Person

Tranche A warrants exercisable 375,000 shares Shares issuable upon exercise of Tranche A Warrants (immediately exercisable)

Tranche B warrants exercisable 375,000 shares Shares issuable upon exercise of Tranche B Warrants (immediately exercisable)

Common Stock Purchase Warrant exercisable 424,358 shares Shares issuable upon exercise of the Common Stock Purchase Warrant (immediately exercisable)

Shares outstanding used 11,778,307 shares Issuer's Prospectus Supplement cited <date>01/09/2026</date>

Key Terms

Tranche A Warrants, Common Stock Purchase Warrant, beneficially owned

3 terms

Tranche A Warrants financial

"shares issuable upon exercise of Tranche A Warrants that are immediately exercisable"

Common Stock Purchase Warrant financial

"424,358 shares of Common Stock issuable upon exercise of the Common Stock Purchase Warrant"

A common stock purchase warrant is a tradable certificate that gives its holder the right to buy a company’s common shares at a fixed price for a set period. Think of it as a coupon that lets you buy stock later at today’s agreed price; it can amplify gains if the share price rises but also can increase the total number of shares outstanding, which may reduce existing owners’ percentage of the company. Investors watch warrants because they offer leveraged upside and can affect future share value and ownership.

beneficially owned regulatory

"Amount beneficially owned: 1915650"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Clene Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

G8959N130

(CUSIP Number)

01/09/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G8959N130

1

Names of Reporting Persons

Ugwumba Chidozie

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,915,650.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,915,650.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,915,650.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

14.8 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: With regard to the number of shares reported in response to (5), (7), and (9) above, the number represents (i) 741,292 shares of Common Stock of the Issuer, (ii) 375,000 shares of Common Stock issuable upon exercise of Tranche A Warrants that are immediately exercisable, (iii) 375,000 shares of Common Stock issuable upon exercise of Tranche B Warrants that are immediately exercisable, and (iv) 424,358 shares of Common Stock issuable upon exercise of the Common Stock Purchase Warrant that is immediately exercisable. The foregoing is based on 11,778,307 shares of the Issuer's Common Stock issued and outstanding, as represented in the Issuer's Prospectus Supplement on Form 424(b)(5) filed with the Securities and Exchange Commission on January 9, 2026

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Clene Inc.
(b)	Address of issuer's principal executive offices: 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UTAH, 84121.
Item 2.
(a)	Name of person filing: Chidozie Ugwumba (the ?Reporting Person?)
(b)	Address or principal business office or, if none, residence: c/o SymBiosis Capital Management, LLC 609 SW 8th St., Suite 510, Bentonville, AR 72712
(c)	Citizenship: United States of America
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: G8959N130
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1915650
(b)	Percent of class: 14.8 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1915650
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1915650
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Ugwumba Chidozie

Signature:	/s/ Chidozie Ugwumba
Name/Title:	Reporting Person
Date:	05/14/2026

FAQ

What stake does Chidozie Ugwumba report in CLNN?

The filing reports 1,915,650 shares beneficially owned, equal to 14.8% of CLNN common stock based on 11,778,307 shares outstanding per the Prospectus Supplement dated 01/09/2026. The amount includes exercised warrants.

How is the 1,915,650 share total composed?

The total includes 741,292 issued shares, 375,000 shares from Tranche A warrants, 375,000 from Tranche B warrants, and 424,358 from a Common Stock Purchase Warrant, all described as immediately exercisable in the filing.

Does the filing state who controls voting and disposition of the shares?

Yes. The filing states the reporting person holds sole voting power and sole dispositive power for 1,915,650 shares, with shared powers reported as 0 in the disclosed fields.

What outstanding share base is the ownership percentage calculated from?

The 14.8% ownership percentage is calculated using 11,778,307 shares issued and outstanding as cited from the Issuer's Prospectus Supplement filed on 01/09/2026